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Introduction
The lectin pathway is activated by the mannose-binding
lectin (MBL) and ﬁcolins (FCN), both have already been
associated with several autoimmune disorders. Here, we
assessed FCN1 and FCN2 functional SNPs in 203 type 1
diabetes mellitus (T1D) patients with celiac disease (CD)
and autoimmune thyroiditis (AITD). We identiﬁed that the
FCN1 rs1071583 SNP was correlated with earlier age of
T1D diagnosis and the combination analysis from the SNPs
(rs2989727 and rs1071583) assessed in FCN1 and FCN2 was
associated with T1D lower susceptibility. This is the ﬁrst
ﬁnding that suggested the genetic role of FCN1 and FCN2 in
northeastern Brazilian children and adolescents with T1D.
The lectin pathway of complement system acts in the elim-
ination of pathogens, being able to phagocyte and induce
inﬂammation response. The lectin pathway is activated by
two different lectins, the mannose-binding lectin (MBL)
and ﬁcolins. So far, three humans ﬁcolins are described:
M-ﬁcolin (ﬁcolin-1), L-ﬁcolin (ﬁcolin-2) and H-ﬁcolin
(ﬁcolin-3), encoded by the FCN1, FCN2 and FCN3 genes,
respectively (Messias-Reason et al. 2009b; Hu et al. 2013).
Several studies suggested the role of ﬁcolins and MBL in
the development of autoimmune disorders due to their abil-
ity to promote the apoptotic bodie’s clearance, to increase
the inﬂammation and to avoid viral infection (Atkinson et al.
2004; Vander Cruyssen et al. 2007; Messias-Reason et al.
2009a). In this study, we assessed the possible inﬂuence of
FCN1 and FCN2 functional SNPs in T1D development and
the insurgence of related AITD and CD.
∗For correspondence. E-mail: crovelser@gmail.com.
Although FCN1 and FCN2 genes are located at the same
chromosome region, 9q34 presents a differential expression
pattern. FCN1 is mainly expressed by leukocytes in intracel-
lular secretory granules and is secreted in the interstitium and
plasma. FCN2 is expressed in liver cells and ﬁcolin-2 protein
once produced is secreted in the plasma (Garred et al. 2009).
Therefore, our hypothesis is that decrease in ﬁcolins pro-
duction/function in interstitium or plasma, related to the pres-
ence of such SNPs, located at regulatory region of FCN1 and
FCN2 genes, may be responsible for apoptotic bodies’ accu-
mulation with a future autoimmune response in pancreatic
tissues. Moreover, these SNPs in FCN1 and FCN2 could be
involved with the autoantibody production in the AITD and
CD in T1D patients.
Material and methods
Patients and healthy individuals
The study was carried out at three pediatric endocrinol-
ogy reference services in Pernambuco, Brazil (Instituto de
Medicina Integral Professor Fernando Figueira, Hospital da
Restauração e Hospital das Clínicas), from March 2010 to
December 2013. Children and adolescents were diagnosed
with T1D according to American Diabetes Association crite-
ria (2012). Ethics committee (Instituto de Medicina Integral
Professor Fernando Figueira, number 1717/2010) approved
the project and patients assigned a written free and informed
consent.
We enrolled 204 T1D subjects (median age 13.5 years)
diagnosed with T1D and 193 healthy individuals (median
age 30 years), without clinical signs or family history of T1D
and not related to the patient group, as controls. Both T1D
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patients and healthy individuals were born and reared in the
same geographical region of Recife, Pernambuco, Brazil.
As Brazilians are considered an admixed population, due
to recent events of European and African migrations, we
previously studied the ethnical composition of Recife pop-
ulation to avoid spurious association: we used 12 genetic
ancestries in formative markers (AIMs) described by Kosoy
et al. (2009), demonstrating a contribution of 59.7%, 23%
and 17.3% of European, African and Native Amerindian
ancestry, respectively (Coelho et al. 2015).
Diagnosis of autoimmune thyroid and celiac disease
Antibodies to thyroid peroxidase (anti-TPO) and antitransgluta-
minase (anti-tTG) were determined by chemio-luminescence
(anti-TPO Ab, diagnostic products IMMULITE, Los Ange-
les) and by ELISA kit I-tTG (Eurospital, Trieste, Italy),
respectively, following manufacturer’s instructions.
DNA extraction
Genomic DNA was extracted from peripheral whole blood
using Wizard Genomic DNA puriﬁcation kit (Promega,
Madison, USA) according to the standard laboratory protocols.
Polymorphism selection and genotyping
After in silico and literature search, we selected ﬁve SNPs:
−1981 (rs2989727) and 7919 (rs1071583) located at pro-
moter region and in exon 9 of FCN1 gene, respectively,
and −4 (rs17514136), +5839 (rs3124954) and +6424
(rs7851696) located at 5′UTR, intron 1 and exon 8 of FCN2
gene, respectively. SNP in 5′UTR region of FCN2 have been
associated with variations in serum concentration of the pro-
tein, whereas the polymorphism located in exon 8, which
encodes the domain similar to ﬁbrinogen has been associated
with an increase in the ability to link the acetylated residues
of the protein (Luz et al. 2013). The rs3124954 represents a
haploblock tagged by rs3128624 of FCN2 gene.
The SNPs at promoter and exon 9 of FCN1 could regu-
late both the expression and synthesis of ﬁcolin-1 and were
previously associated with autoimmune disorder (Vander
Cruyssen et al. 2007). The rs1071583 of FCN1 is synony-
mous SNP that changes dramatically the frequency of codon
usage in the translation process, there by altering the rate of
bioavailable protein and is associated with other autoimmune
events (http://www.kazusa.or.jp/codon/).
Genotyping was performed using commercially available
TaqMan probes (Applied Biosystem, Foster City, USA).
The rs2989727 and rs1071583, by C_26745032_10 and
C_1819018_1_, respectively. The rs17514136, rs3124954
and rs7851696, by C_25765134_10, C_27462209_20 and
C_29220549_20), respectively. TaqMan reactions were set
up based on the manufacture’s protocol using 7500 Real-
Time PCR instrument (Applied Biosystem).
Statistical analysis
Allelic discrimination was performed as suggested by
the manufacturer (TaqMan R© Genotyping Software), and
analysed using Genotyping Transposer software. Using the R
statistical package (https://www.r-project.org), we obtained
the chi-square test to correlate polymorphism distribution
with the susceptibility to develop T1D and its clinical fea-
tures as well as to evaluate the Hardy–Weinberg equilib-
rium (HWE). Linkage disequilibrium (LD) within FCN1
and FCN2 SNPs and haplotype constructions were assessed
using the Haploview and SNPstats softwares (ver. 4.2).
Odds ratio (OR) and 95% conﬁdence intervals (CI) were
also computed. All analyses, P-value <0.05 were con-
sidered statistically signiﬁcant. Power analyses were per-
formed using G*Power 3.1.9.2 software (http://www.psycho.
uniduesseldorf.de). The association with the age of T1D
onset was performed using the package SNPassoc, imple-
mented in statistical software R (ver. 3.0.0, http://www.
r-project.org).
Results
In this study, a total of ﬁve SNPs, two SNPs of FCN1 and
three of FCN2 genes were analysed in 204 T1D patients and
193 healthy subjects, classiﬁed according to the presence of
other autoimmune disorder, namely CD and AITD.
Allele and genotype frequencies of FCN1 gene polymor-
phisms (rs2989727 and rs1071583) were in HWE in both
T1D patients and healthy individuals groups. The FCN2
SNPs frequencies were also in HWE, except for rs7851696
(+6424 G>T variant) in both groups. No statistical differ-
ences were found in the SNPs distribution of T1D patients,
CD and AITD subgroups and healthy individuals (P > 0.05)
in all genetic models, i.e. codominant, dominant, reces-
sive, overdominant and log-additive (data not shown). Only
rs1071583 at FCN1 was associated with age-at-diagnosis of
T1D (P: 0.016; Akaike information criterion (AIC): 1095;
dif: −2.20; 95% CI: −3.997 to −0.419; table 1). This asso-
ciation shows the genotype T/T as major susceptibility risk
factor for an earlier insurgence of diabetes when compared
to C/C and C/T genotypes. Patients with T/T genotypes
could develop T1D around two years earlier than the others
patients. No statistical association with the sex distribution
was obtained for all ﬁve loci (P > 0.05, data not shown).
Since SNPs may act in combination to increase the risk
of disease, the haplotypes of the studied FCNs SNPs were
investigated and their frequencies in T1D and healthy con-
trol groups were compared. In spite of lack of strong LD
between rs2989727 and rs1071583 SNPs (D′ = 0.2), indi-
viduals carrying the C allele at both SNPs showed some pro-
tection against T1D onset (P value: 0.0003, OR: 0.53, 95%
CI = 0.38–0.75) as shown in table 2.
Discussion
T1D is a multifactorial autoimmune disease caused by one
or more environmental factors, such as viruses and bacterial
toxins, interacting with the genetic proﬁle of the individual
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Table 1. Association between age of onset of type 1 diabetes and polymorphism in rs1071583 of FCN1 gene.
rs1071583 N Av. SD Dif. LL UL P value AIC
Codominant C/C 91 7.86 0.42 0.002 – – 0.05 1097
C/T 81 7.52 0.48 −0.34 −1.549 0.87
T/T 22 5.45 0.63 −2.37 −4.25 −0.49
Dominant C/C 91 7.86 0.42 0.00 – – 0.19 1100
C/T–T/T 103 7.09 0.41 −0.77 −1.92 0.37
Recessive C/C–C/T 172 7.70 0.32 0.00 – – 0.02 1095
T/T 22 5.49 0.63 −2.21 −3.98 −0.42
Overdominant C/C–T/T 113 7.40 0.37 0.00 – – 0.84 1101
C/T 81 7.52 0.48 0.12 −1.41 1.29
Log additivate 0.1.2 – – – −0.91 −1.75 −0.06 0.04 1097
N, number of individuals; Av., average for a certain genotype; SD, standard deviation of average; Dif., the difference between the averages
of certain genotype with genotype reference; LL, lower limit of the CI of difference; UL, upper limit of the CI of difference; AIC, Akaike
information criterion.
Table 2. Frequencies of haplotypes in FCN1 gene in T1D patients and healthy controls.
FCN1 rs2989727 rs1071583 HC T1D OR (95% CI) P
1 T C 0.2459 0.5050 1.00 –
2 C T 0.1422 0.3216 0.94 (0.65–1.35) 0.72
3 C C 0.4004 0.1734 0.53 (0.38–0.75) 3 × 10−4
4 T T 0.2116 0 0.00 (ND) 1
*Global haplotype association P<0.0001; HC, healthy control; T1D, type 1 diabetes.
(Kyvik et al. 1995; Tsutsumi et al. 2003; Hansen et al. 2004).
In the context of infectious triggering of T1D, it is known
that ﬁcolins can activate the lectin pathway of complement
after binding to various microbial ligands such as mannose
(Ohta et al. 1990), lipoteichoic acid (Lynch et al. 2004),
GlcNAc (Matsushita et al. 1996), lipopolysaccharide (Neth
et al. 2000; Zhao et al. 2002). Thus, it can be assumed that
the reduction or deﬁciency of serum and interstitium ﬁcolin-
1/2 in children and adolescents could be a risk factors for
T1D onset.
Further, as ﬁcolins are involved in the cleaning of apop-
totic bodies, its deﬁciency may also be associated with a poor
removal of apoptotic cells resulting in the spread of autoanti-
gens and immune system activation (Boniotto et al. 2005;
Runza et al. 2008).
The knowledge of ﬁcolin in autoimmune diseases remains
scarce; in fact, in the literature, we found only one genetic
association study with autoimmune disorder. Vander Cruyssen
et al. (2007) described the association of rs2989727 and
rs1071583 in FCN1 with the development of rheumatoid
arthritis. Both SNPs were included in the present study,
but no association with T1D development was found. Fur-
ther, these SNPs were not involved in the insurgence of
CD or AITD or both. As Vander Cruyssen et al. (2007)
demonstrated a strong LD between the SNPs rs2989727
and rs1071583, we also performed LD analysis and found
that the combination of alleles C–C (for the rs2989727
and rs1071583, respectively) were associated with protec-
tion to T1D development, even if these SNPs were not
in LD in our studied population. Unfortunately, Vander
Cruyssen et al. (2007) did not perform the haplotype associ-
ation, limiting our discussion.
The MBL and ﬁcolin proteins may share the same molecu-
lar function and both take part in similar innate immune path-
ways as synonymous proteins, i.e., absence of one protein
could be masked by the presence the other. Thus, we hypoth-
esize that individuals carrying low levels of FCN1 or FCN2
could present normal or even high levels of MBL, thus cre-
ating a balance in the complement activation and apoptotic
clearance.
Despite these major functions and similarities between
MBL and ﬁcolins, the ﬁcolin-1 is the unique to be released by
leukocytes that inﬁltrates the interstitium during the inﬂam-
mation, such as is observed in the triggering T1D, which
the beta-cells are inﬁltrated by reactive T cells generating
an inﬂammatory process termed insulitis. We believe that
the absence of ﬁcolin-1 in the microenvironment of the
inﬂammatory process in pancreas tissues will not be bal-
anced by the MBL presence. However, according to our
results this hypotheses was not conﬁrmed, corroborating
Munthe-Fog et al. (2012) ﬁndings that demonstrated that
the rs2989727 do not inﬂuence the FCN1 expression in
monocytes. Interestingly, children carrying the T/T genotype
(rs1071583 of FCN1) presented an earlier age of diagnosis
compared with genotypes C/C or C/T in a recessive model.
The rs1071583 is a synonymous SNP at exon 9, that changes
CAA to CAG, and the codon CAA has lower codon usage
related to CAG (12.3 versus 34.2 per thousand of transcrip-
tion) http://www.kazusa.or.jp/codon/, consequently, individ-
uals carrying the genotype T/T (i.e. the codon CAA) could
produce smaller quantity of ﬁcolin 1. This ﬁnding suggests
that FCN1 is not directly implicated in triggering T1D onset
but it could be involved in enhancing its consequences by
creating a favourable environment for chronic conditions
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in T1D patients. After the initial autoimmune response, the
recruitment of leucocytes that produce a smaller quantity of
ﬁcolin 1 could diminish the apoptotic clearance and antici-
pating the autoimmune proﬁle. However, further functional
studies should be performed to clarify this hypothesis.
Conclusion
This is the ﬁrst report to study the genetic role of FCN1
and FCN2 in northeastern Brazilian children and adolescents
with T1D. FCN1 rs1071583 SNP was correlated with ear-
lier age of T1D diagnosis. In addition, the SNP combination
rs2989727 and rs1071583 was involved with T1D protection.
We are aware of the limitations of our study, related basically
to the low number of individuals analysed as well as to the
absence of functional validation (ELISA, Western, etc.) of
the impact of FCN1 and FCN2 SNPs on the production and
functionality of the proteins: thus both genetic replica and
immunological functional studies should be done to increase
the knowledge of FCN genes in the development of T1D.
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